ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
T.S.S RAJAN M.D

Cardiovascular Disease

2,238

$74.8K

70
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$33
Average prescription price

Avg: $67

JIHAD AL IMAMI M.D.

Cardiovascular Disease

3,049

$449K

200
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 28%

$147
Average prescription price

Avg: $67

MIRKO GIACONI

Cardiovascular Disease

8,352

$656K

312
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $67

DALE STEMPLE M.D.

Cardiovascular Disease

10,989

$723K

410
270 are 65+

23%
patients receiving schedule two controlled substances

Avg: 0%

34%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $67

JOHN SMITH MD

Cardiovascular Disease

8,693

$605K

275
247 are 65+

9%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$70
Average prescription price

Avg: $67

DAVID KATTAN M.D.

Cardiovascular Disease

8,511

$572K

387
330 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $67

RAZMIK OHANJANIAN MD

Cardiovascular Disease

43,890

$3.05M

723
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $67

VINOD MALHOTRA MD

Cardiovascular Disease

10,188

$531K

478
340 are 65+

9%
patients receiving schedule two controlled substances

Avg: 0%

22%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $67

JOSE ROCAMORA MD

Cardiovascular Disease

45,055

$2.14M

1473
1174 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $67

ROLLINGTON FERGUSON MD

Cardiovascular Disease

12,011

$907K

546
325 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

26%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 28%

$75
Average prescription price

Avg: $67

CHIN SHUN SHIH M.D.

Cardiovascular Disease

19,572

$1.19M

937
903 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $67

OSCAR ZAMBRANO M.D.

Cardiovascular Disease

22,733

$918K

1008
870 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$40
Average prescription price

Avg: $67

AFSHINE EMRANI MD

Cardiovascular Disease

25,794

$3.1M

629
555 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 28%

$120
Average prescription price

Avg: $67

PRAMOD MULTANI MD

Cardiovascular Disease

21,714

$1.21M

781
673 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $67

TOM YEH M.D.

Cardiovascular Disease

28,209

$1.52M

772
749 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$54
Average prescription price

Avg: $67

GUSTIN HO M.D.

Cardiovascular Disease

21,804

$1.49M

1208
1174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

MICHAEL NORMAN DO

Cardiovascular Disease

21,812

$1.15M

1157
938 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $67

LINDA FONG M.D.

Cardiovascular Disease

706

$32.4K

203
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $67

HENNESSEY TSENG M.D.

Cardiovascular Disease

2,665

$178K

268
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $67

JOHN MESSENGER

Cardiovascular Disease

3,111

$247K

270
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $67

JOHN CARSON M.D.

Cardiovascular Disease

1,894

$148K

137
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $67

SAMUEL SMITH MD

Cardiovascular Disease

3,866

$293K

143
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $67

CURTIS SMITH MD

Cardiovascular Disease

3,427

$107K

262
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 28%

$31
Average prescription price

Avg: $67

ANNA MILSTEIN M.D.

Cardiovascular Disease

23,986

$2.21M

664
618 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $67

HIEU HUYNH MD

Cardiovascular Disease

2,907

$181K

271
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank